New Alzheimer’s contender Vandria clears key hurdle

Early human data suggest Vandria’s drug candidate VNA-318 may validate a new way of tackling age-related brain disease. In Alzheimer’s research, are scientists fighting the wrong battle? The field has spent decades trying to remove the sticky amyloid plaques that accumulate in the brain, yet the clinical benefits have often been modest and hotly debated. […] The post New Alzheimer’s contender Vandria clears key hurdle appeared first on Longevity.Technology .

This story was reported by Longevity.Technology. EUROPES curates Europe's most relevant coverage — read the full report at the original source.